PHAS Annual CFI
-$2.68 M
-$1.27 M-89.73%
31 December 2021
Summary:
As of January 25, 2025, PHAS annual cash flow from investing activities is -$2.68 million, with the most recent change of -$1.27 million (-89.73%) on December 31, 2021. During the last 3 years, it has fallen by -$2.56 million (-2151.26%).PHAS Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PHAS Quarterly CFI
-$58.00 K
-$9000.00-18.37%
30 June 2022
Summary:
As of January 25, 2025, PHAS quarterly cash flow from investing activities is -$58.00 thousand, with the most recent change of -$9000.00 (-18.37%) on June 30, 2022. Over the past year, it has increased by +$194.00 thousand (+76.98%).PHAS Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PHAS TTM CFI
-$2.40 M
+$194.00 K+7.48%
30 June 2022
Summary:
As of January 25, 2025, PHAS TTM cash flow from investing activities is -$2.40 million, with the most recent change of +$194.00 thousand (+7.48%) on June 30, 2022. Over the past year, it has dropped by -$1.78 million (-288.51%).PHAS TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PHAS Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -89.7% | +77.0% | -288.5% |
| 3 y3 years | -2151.3% | +83.2% | -150.1% |
| 5 y5 years | -1140.3% | - | -150.1% |
PHAS Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | -129.0% | +1833.3% | >+9999.0% |
PhaseBio Pharmaceuticals Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2022 | - | -$58.00 K(+18.4%) | -$2.40 M(-7.5%) |
| Mar 2022 | - | -$49.00 K(-97.0%) | -$2.60 M(-3.1%) |
| Dec 2021 | -$2.68 M(+89.7%) | -$1.66 M(+159.6%) | -$2.68 M(+148.5%) |
| Sept 2021 | - | -$638.00 K(+153.2%) | -$1.08 M(+74.4%) |
| June 2021 | - | -$252.00 K(+89.5%) | -$618.00 K(-30.3%) |
| Mar 2021 | - | -$133.00 K(+141.8%) | -$887.00 K(-37.2%) |
| Dec 2020 | -$1.41 M(+47.1%) | -$55.00 K(-69.1%) | -$1.41 M(-5.4%) |
| Sept 2020 | - | -$178.00 K(-65.8%) | -$1.49 M(-12.7%) |
| June 2020 | - | -$521.00 K(-20.8%) | -$1.71 M(+11.5%) |
| Mar 2020 | - | -$658.00 K(+383.8%) | -$1.53 M(+59.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | -$960.00 K(+706.7%) | -$136.00 K(-65.6%) | -$960.00 K(+5.3%) |
| Sept 2019 | - | -$395.00 K(+14.5%) | -$912.00 K(+75.4%) |
| June 2019 | - | -$345.00 K(+310.7%) | -$520.00 K(+164.0%) |
| Mar 2019 | - | -$84.00 K(-4.5%) | -$197.00 K(+65.5%) |
| Dec 2018 | -$119.00 K(-44.9%) | -$88.00 K(+2833.3%) | -$119.00 K(+283.9%) |
| Sept 2018 | - | -$3000.00(-86.4%) | -$31.00 K(+10.7%) |
| June 2018 | - | -$22.00 K(+266.7%) | -$28.00 K(+366.7%) |
| Mar 2018 | - | -$6000.00 | -$6000.00 |
| Dec 2017 | -$216.00 K(-102.3%) | - | - |
| Dec 2016 | $9.25 M | - | - |
FAQ
- What is PhaseBio Pharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for PhaseBio Pharmaceuticals?
- What is PhaseBio Pharmaceuticals annual CFI year-on-year change?
- What is PhaseBio Pharmaceuticals quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for PhaseBio Pharmaceuticals?
- What is PhaseBio Pharmaceuticals quarterly CFI year-on-year change?
- What is PhaseBio Pharmaceuticals TTM cash flow from investing activities?
- What is the all time high TTM CFI for PhaseBio Pharmaceuticals?
- What is PhaseBio Pharmaceuticals TTM CFI year-on-year change?
What is PhaseBio Pharmaceuticals annual cash flow from investing activities?
The current annual CFI of PHAS is -$2.68 M
What is the all time high annual CFI for PhaseBio Pharmaceuticals?
PhaseBio Pharmaceuticals all-time high annual cash flow from investing activities is $9.25 M
What is PhaseBio Pharmaceuticals annual CFI year-on-year change?
Over the past year, PHAS annual cash flow from investing activities has changed by -$1.27 M (-89.73%)
What is PhaseBio Pharmaceuticals quarterly cash flow from investing activities?
The current quarterly CFI of PHAS is -$58.00 K
What is the all time high quarterly CFI for PhaseBio Pharmaceuticals?
PhaseBio Pharmaceuticals all-time high quarterly cash flow from investing activities is -$3000.00
What is PhaseBio Pharmaceuticals quarterly CFI year-on-year change?
Over the past year, PHAS quarterly cash flow from investing activities has changed by +$194.00 K (+76.98%)
What is PhaseBio Pharmaceuticals TTM cash flow from investing activities?
The current TTM CFI of PHAS is -$2.40 M
What is the all time high TTM CFI for PhaseBio Pharmaceuticals?
PhaseBio Pharmaceuticals all-time high TTM cash flow from investing activities is -$6000.00
What is PhaseBio Pharmaceuticals TTM CFI year-on-year change?
Over the past year, PHAS TTM cash flow from investing activities has changed by -$1.78 M (-288.51%)